Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.71 |
| ▸ | GLA | P06280 | 2/20 | 0.71 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.63 |
| ▸ | HTR1A | P08908 | 1/20 | 0.63 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.63 |
| ▸ | HTR2A | P28223 | 1/20 | 0.63 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.63 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.63 |
| ▸ | HTR2B | P41595 | 1/20 | 0.63 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.63 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | DRD4 | P21917 | 5/20 | 0.51 |
| ▸ | TP53 | P04637 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26253967 | 1.00 | ALDH1A1 (0.71) | ALDH1A1GLAADRB2HTR1ASLC6A2 | |
| SCHEMBL22357196 | 0.90 | ALDH1A1 (0.78) | ALDH1A1GLAADRB2HTR1ASLC6A2 | |
| SCHEMBL679937 | 0.90 | ALDH1A1 (0.78) | ALDH1A1GLAADRB2HTR1ASLC6A2 | |
| SCHEMBL29151469 | 0.86 | ALDH1A1 (0.67) | ALDH1A1GLAADRB2HTR1ASLC6A2 | |
| SCHEMBL29769262 | 0.85 | ALDH1A1 (0.71) | ALDH1A1GLAADRB2HTR1ASLC6A2 | |
| SCHEMBL93244 | 0.85 | ALDH1A1 (0.71) | ALDH1A1GLAADRB2HTR1ASLC6A2 | |
| SCHEMBL3634571 | 0.85 | ALDH1A1 (0.71) | ALDH1A1GLAADRB2HTR1ASLC6A2 | |
| SCHEMBL7282918 | 0.85 | ALDH1A1 (0.71) | ALDH1A1GLAADRB2HTR1ASLC6A2 | |
| SCHEMBL6894135 | 0.85 | ALDH1A1 (0.70) | ALDH1A1GLAADRB2HTR1ASLC6A2 | |
| SCHEMBL7282087 | 0.84 | ALDH1A1 (0.65) | ALDH1A1GLAADRB2HTR1ASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120025500-A | Photopolymer holographic recording medium, preparation method and application thereof | 珠海莫界科技有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-119889530-A | Photopolymer holographic recording medium, volume hologram grating, optical waveguide, and apparatus | 珠海莫界科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119889529-A | Photopolymer holographic recording medium, volume hologram grating, optical waveguide, and apparatus | 珠海莫界科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119798564-A | Photopolymer holographic recording medium, grating, preparation method and equipment thereof | 珠海莫界科技有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-118290739-A | Siloxane modified curing agent, underfill material and preparation method thereof | 中国科学院深圳先进技术研究院 | 2024-07-05 | — | — | CN | claimed |
| CN-117567973-B | High Tg underfill and preparation method thereof | 深圳先进电子材料国际创新研究院 | 2024-04-09 | — | — | CN | claimed |
| CN-117567973-A | High Tg underfill and preparation method thereof | 深圳先进电子材料国际创新研究院 | 2024-02-20 | — | — | CN | claimed |
| CN-113387872-A | Preparation method and application of compound | 山东第一医科大学(山东省医学科学院) | 2021-09-14 | — | — | CN | claimed |
| US-20190300492-A1 | METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF | SUPERNUS PHARMACEUTICALS, INC. (US) | 2019-10-03 | — | — | US | claimed |
| US-9403783-B2 | Methods for producing viloxazine salts and novel polymorphs thereof | SUPERNUS PHARMACEUTICALS, INC. (US) | 2016-08-02 | — | — | US | claimed |
| US-20150126735-A1 | METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF | SUPERNUS PHARMACEUTICALS INC. (US) | 2015-05-07 | — | — | US | claimed |
| EP-2558437-A2 | METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF | Supernus Pharmaceuticals, Inc. (US) | 2013-02-20 | — | — | EP | claimed |
| WO-2011130194-A2 | METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF | SUPERNUS PHARMACEUTICALS INC. (US) | 2011-10-20 | — | — | WO | claimed |
| US-20110251198-A1 | METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF | SUPERNUS PHARMACEUTICALS INC. (US) | 2011-10-13 | — | — | US | claimed |
| US-20260062395-A1 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF VILOXAZINE AND OTHER 2-SUBSTITUTED MORPHOLINE DERIVATIVES | CURIA SPAIN S A U (ES) | 2026-03-05 | — | — | US | disclosed |
| CN-121045102-A | Preparation method of viloxazine hydrochloride | 山东达因海洋生物制药股份有限公司 | 2025-12-02 | — | — | CN | disclosed |
| EP-4565571-A1 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF VILOXAZINE AND OTHER 2-SUBSTITUTED MORPHOLINE DERIVATIVES | CURIA SPAIN, S.A.U. (ES) | 2025-06-11 | — | — | EP | disclosed |
| US-4363805-A | TREATMENT OF CORONARY DISEASE | FIRMA WILLMAR SCHWABE (DE) | 1982-12-14 | — | — | US | disclosed |
| EP-0044940-A1 | Amino-desoxy-1.4;3.6-dianhydro-hexite nitrates, processes for their preparation and pharmaceutical compositions | Dr. Willmar Schwabe GmbH & Co. (DE) | 1982-02-03 | — | — | EP | disclosed |
| US-4018778-A | ADRENALYTIC OR ANTIARRYTHMIC AGENTS | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1977-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190300492-A1 | METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF | CYP3A5, VIL1, CYP3A4 | ALDH1A1 346/4885GLA 1390/4885ADRB2 1041/4885 |
| US-20260062395-A1 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF VILOXAZINE AND OTHER 2-SUBSTITUTED MORPHOLINE DERIVATIVES | OGFRL1, SALL4, OGFR | ALDH1A1 1353/4885GLA 3588/4885ADRB2 1206/4885 |
| US-20150126735-A1 | METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF | CYP3A5, VIL1, CYP3A4 | ALDH1A1 346/4885GLA 1390/4885ADRB2 1041/4885 |
| US-20110251198-A1 | METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF | CYP3A5, VIL1, CYP3A4 | ALDH1A1 346/4885GLA 1390/4885ADRB2 1041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.